| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0360-3016(02)02731-1 |
| P698 | PubMed publication ID | 12023142 |
| P2093 | author name string | Jan C Buckner | |
| Ravi D Rao | |||
| Robert P Dinapoli | |||
| John D Earle | |||
| Stephan D Thomé | |||
| Judith O'Fallon | |||
| P2860 | cites work | Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineli | Q30660196 |
| Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme | Q31861401 | ||
| Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study | Q33329329 | ||
| A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme | Q33329945 | ||
| Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study | Q33337565 | ||
| Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial | Q33453675 | ||
| Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery | Q33483488 | ||
| National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma. | Q33490942 | ||
| Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study | Q34239497 | ||
| Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma | Q38271145 | ||
| Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. | Q38652757 | ||
| Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources | Q39680145 | ||
| An analysis of dose-effect relationship in the radiotherapy of malignant gliomas | Q40285820 | ||
| Accelerated hyperfractionated radiotherapy for malignant gliomas | Q40949497 | ||
| Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report | Q43959088 | ||
| A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02 | Q44280566 | ||
| Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas | Q46093579 | ||
| Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults | Q48303492 | ||
| Misonidazole combined with hyperfractionation in the management of malignant glioma | Q48632169 | ||
| Superfractionation radiation therapy in the treatment of malignant astrocytoma | Q48711281 | ||
| Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery | Q48858120 | ||
| Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas. A pilot feasibility study of the Radiotherapy Group of the EORTC. | Q48891716 | ||
| Super fractionation in glioblastoma multiforme-results of a phase II study | Q48892731 | ||
| Biologic basis for altered fractionation schemes. | Q54519529 | ||
| Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma. | Q55475071 | ||
| Accelerated hyperfractionated radiation therapy for malignant glioma. A phase II study. | Q55480431 | ||
| Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study. | Q55481518 | ||
| Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study. | Q55481861 | ||
| Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302. | Q55483140 | ||
| A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma | Q55483561 | ||
| Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial | Q55489648 | ||
| Radiation tolerance of the rat spinal cord: time-dose relationships | Q67543670 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 376-384 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | Safety of thrice-daily hyperfractionated radiation and BCNU for high-grade gliomas | |
| P478 | volume | 53 |
| Q81086312 | Central nervous system tumors |
| Q92446489 | Survival impact of prolonged postoperative radiation therapy for patients with glioblastoma treated with combined-modality therapy |
| Q35688316 | The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme |
Search more.